• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Evotec AG - Articles and news items

sembragiline

Sembragiline fails to meet primary endpoint in Phase IIb trial in Alzheimer’s disease

Industry news / 2 July 2015 / Victoria White

Evotec and Roche have provided an update on the initial results of the Phase IIb trial with Sembragiline for the treatment of Alzheimer’s disease…

evotec_logo

Evotec receives milestone as part of its multi-target alliance with Bayer HealthCare

Industry news / 13 October 2014 / Evotec

Evotec AG announced that its multi-target collaboration with Bayer HealthCare has reached an important milestone for the transition of a molecule into pre-clinical development for the treatment of endometriosis…

evotec_logo

Evotec and Roche to develop compound that could slow the progression of Alzheimer’s disease

Industry news, News / 6 September 2011 / Evotec AG

Evotec’s MAO-B inhibitor in patients with Alzheimer’s disease (AD) to be developed…

Roche logo

Roche and Evotec to jointly develop biomarkers in oncology

Industry news, News / 24 June 2011 / Roche

Roche and Evotec AG announced a collaboration in novel protein-activity based biomarkers for Roche’s oncology drugs…

evotec_logo

Twelfth milestone payment as part of its discovery alliance with Boehringer Ingelheim received

Industry news, News / 9 May 2011 / Evotec AG

Twelfth milestone triggers payment of EUR 2 million to Evotec…

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +